The authors found that interlobular hyaline arteriopathy (IHA) in renal allografts is associated with severe arteriolopathy, and older grafts exhibited more IHA lesions.
Methods: Tissue specimens that included the interlobular artery from biopsies performed from January 2012 to December 2015, as well as specimens from biopsies performed ≥1 year after living kidney transplantation were analyzed. Biopsies of recipients with new-onset diabetes mellitus after transplantation were excluded, as well as those of recipients who had undergone transplantation because of diabetic nephropathy. Arteriolopathy was evaluated using the aah score determined by the Banff 2007 classification.
Results: In total, 51 specimens with IHA lesions were identified among 381 biopsies obtained from 243 recipients performed ≥1 year after kidney transplantation. Among these 51 biopsies, 18 specimens had a score of aah3, 29 had a score of aah2, and four had a score of aah1. The incidence of IHA lesions was 3.6% at ≥1 to <4 years, 18.5% at ≥4 to <8 years, and 54.1% at ≥8 years. Older kidney grafts exhibited more IHA lesions. Among the biopsy specimens obtained ≥8 years after transplantation, no significant differences in the recipient or donor age, duration after transplantation, or prevalence of hypertension were observed between the IHA and non-IHA groups. The aah scores were significantly higher in the IHA group ≥8 years after transplantation as determined by the mean score test (P < 0.01).
Conclusion: IHA in renal allografts is associated with severe arteriolopathy.
A previous report has described that in cyclosporine arteriolopathy, protein deposits replace smooth muscle cells in the arteriolar wall, and this type of arteriolopathy predominates in the afferent arterioles. 1 According to the Banff 2007 classification, the aah scoring system was proposed as a new scoring method for calcineurin inhibitor (CNI) arteriolopathy, and the aah score is used to evaluate the replacement of degenerated smooth muscle cells by hyaline deposits. 2 It has been hypothesized that the adverse effects of cyclosporine on long-term graft function play an important role in chronic allograft dysfunction. 3 Moreover, in 10-year protocol biopsies muscular arteriolar hyaline deposits were found in 68% of kidney transplant recipients undergoing treatment with cyclosporine. 4 However, complete regression of cyclosporine arteriolopathy is frequently found after discontinuation or reduction of cyclosporine, even if the arterioles are severely affected. 5 Therefore, accurate evaluation of the severity of arteriolopathy in the late phase of renal allografts is vitally important. The aah score is mainly determined by evaluation of hyaline deposits in the arterioles. 2 However, the clinicopathological significance of the replacement of smooth muscle cells in the interlobular artery by hyaline deposits remains unclear. Therefore, in this study, we focused on the replacement of smooth muscle cells in the interlobular artery by these hyaline lesions.
We henceforth refer to these lesions as interlobular hyaline arteriopathy (IHA). IHA was observed in both the main portion of the interlobular artery, located in the boundary between the cortex and medulla, and in the peripheral portion of the interlobular artery, opposite the main portion. The aim of this study was to determine the clinicopathological significance of IHA in renal allografts.
METHODS Patients
At our hospital, protocol biopsies are usually performed 1 h, 3 months, 1 year, 3 years, 7 years, and in some recipients, 10 years after transplantation. We analyzed tissue specimens that included the interlobular artery from protocol or episode biopsies performed at our hospital from January 2012 to December 2015, as well as specimens from biopsies performed ≥1 year after living kidney transplantation at our hospital. We excluded the biopsies of recipients with new-onset diabetes mellitus after transplantation according to the Japanese Criteria 2012, 6 or those of recipients who had undergone kidney transplantation because of diabetic nephropathy. At our hospital, the basic immunosuppressive therapy regimen involves tacrolimus or cyclosporine, methylprednisolone, mycophenolate mofetil or azathioprine, and basiliximab (from 2002 onward). The trough concentration of tacrolimus or cyclosporine was evaluated at the time of biopsy. Hypertension was defined as taking oral anti-hypertensive medication at the time of biopsy.
Histopathology
We determined the histological score using the Banff 1997 and 2007 classifications. 2, 7 Haematoxylin and eosin, periodic acid-Schiff, periodic acid-methenamine silver, and Masson trichrome staining are routinely used to stain renal allograft biopsy sections for light microscopy at our hospital. We evaluated hyaline lesions of the arterioles and interlobular artery by periodic acid-Schiff staining. Immunodetection of C4d was performed on frozen sections using C4d antibody (Quidel, Athens, OH, USA). We evaluated hyaline arteriolopathy by the aah score as defined by the Banff 2007 classification ( Fig. 1A) , 2 and defined an arteriole as comprising one myocyte. We defined the main portion of the interlobular artery as the part of the interlobular artery composed of ≥ two myocytes, with minimal connective tissue, located in the boundary between the cortex and medulla (Fig. 1B) , and excluding the arcuate artery which was distinguished by prominent connective tissue around the artery. The peripheral portion of the interlobular artery was defined as the part of the interlobular artery opposite the main portion and containing two or three myocytes (Fig. 1C) . IHA lesions in the main portion of the interlobular artery were defined as main IHA, and IHA lesions in the peripheral portion of the interlobular artery were defined as peripheral IHA. Interlobular arteriosclerosis in the one-hour biopsy specimen was identified based on the existence of fibrous thickening in the interlobular artery. We analyzed the most prominent fibrous intimal thickening in the interlobular artery at the time of biopsy by evaluating the intima-to-media ratio, and defined the intima-to-media ratio grade as follows: ratio of 0, grade 0; ratio of >0 and <1, grade 1; and ratio of ≥1, grade 2. 8 We defined a biopsy finding of acute/active antibody-mediated rejection as histological evidence of acute tissue injury and endothelial injury (C4d deposition in peritubular capillaries or microvascular inflammation). 9 Histological evaluation of biopsies was performed by at least two expert pathologists.
Statistical analysis
We analyzed all data using SPSS version 23.0 software for Windows (IBM Japan, Tokyo, Japan). A P-value of <0.05 was considered to indicate statistically significant differences. We compared variables using the χ 2 test, Fisher's exact test, the Mann-Whitney U-test, and Student's t-test. A mean score test was used to evaluate differences in the distribution of aah scores between the IHA group and non-IHA group. Data are presented as either number (%) or mean AE standard deviation. This study was approved by the Ethics Committee of Toho University Omori Medical Center (approval number 27-260).
RESULTS
aah Scores of tissue specimens containing IHA lesions from biopsies performed ≥1 year after transplantation
Among the 381 biopsy specimens obtained from 243 transplant recipients, 51 specimens (13.4%) containing IHA lesions were identified from biopsies performed ≥1 year after transplantation. Table 1 shows the distribution of the aah scores of these biopsy specimens. Among the 51 specimens with IHA lesions, 18 had a score of aah3, 29 had a score of aah2, and four had a score of aah1. Furthermore, of these biopsies with IHA lesions, 35 biopsies demonstrated peripheral IHA, and 16 had main or main + peripheral IHA. Of the biopsies with peripheral IHA, 10 had a score of aah3, 22 had a score of aah2, and three had a score of aah1. Of the biopsies with main or main + peripheral IHA, eight had a score of aah3, seven had a score of aah2, and one had a score of aah1. The aah scores of biopsies with main or main + peripheral IHA were not significantly higher than those with peripheral IHA by the mean score test (P = 0.169).
Incidence of IHA lesions according to time after transplantation Figure 2 shows the incidence of IHA lesions according to the time after transplantation among biopsies performed ≥1 year after transplantation. The prevalence of IHA lesions was 8/220 (3.6%) among biopsies performed ≥1 to <4 years after transplantation, 23/124 (18.5%) among those performed ≥4 to <8 years after transplantation, and 20/37 (54.1%) among those performed ≥8 years after transplantation. Figure 3 shows the localization of IHA lesions according to the time after transplantation. Notably, the prevalence of the combination of peripheral + main IHA lesions was 5/23 (21.7%) among biopsies performed ≥4 to <8 years after transplantation and 8/20 (40%) among those performed ≥8 years after transplantation. The prevalence of main IHA lesions alone was 3/20 (15%) among biopsies performed ≥8 years after transplantation.
Clinical characteristics of IHA and non-IHA groups ≥8 years after transplantation Table 2 shows the clinical characteristics of the IHA and non-IHA groups ≥8 years after transplantation. No significant differences in the sex, recipient age, donor age, duration after transplantation, tacrolimus or cyclosporine trough level, or prevalence of hypertension were observed between the IHA and non-IHA groups. Table 3 shows the serum creatinine levels of the IHA and non-IHA groups at the time of biopsy, at 1 and 2 years after biopsy. The serum creatinine levels at the time of biopsy and at one year after biopsy were not significantly different between the two groups. However, the serum creatinine level 2 years after biopsy was significantly higher in the IHA group compared with the non-IHA group.
Histopathological characteristics of IHA and non-IHA groups ≥8 years after transplantation
The pathological findings of the IHA and non-IHA groups ≥8 years after transplantation are shown in Table 4 . No significant differences in the prevalence of interlobular arteriosclerosis at the 1-h biopsy, cg score, or interlobular arteriosclerosis grade were observed between the two groups. However, the ah score at the 1-h biopsy, ct + ci score, and prevalence of acute/active antibody-mediated rejection were significantly higher in the IHA group compared with the non-IHA group. Differences in the distribution of aah scores between the IHA and non-IHA groups peripheral IHA main IHA aah (A) (B) (C) Fig. 1 Representative images of aah (A), main interlobular hyaline arteriopathy (IHA) (B), and peripheral IHA (C) in renal allograft biopsies from kidney transplant recipients (×400 magnification, PAS staining). ≥8 years after transplantation are shown in Figure 4 . Notably, significantly higher aah scores were observed in the IHA group compared with the non-IHA group (P < 0.01).
DISCUSSION
In this study, older kidney grafts exhibited more IHA lesions. Analysis of biopsy specimens obtained ≥8 years after transplantation showed a high frequency of IHA and high aah scores, and IHA was associated with severe aah lesions in the late kidney grafts. The aah score was determined by evaluating CNI arteriolopathy according to the Banff 2007 classification. 2 A previous study showed that cyclosporine is independently associated with muscular arteriolopathy at the 10-year biopsy after transplantation; however, muscular arteriolopathy is not a specific characteristic of CNI nephrotoxicity. 4 Another study reported that the blood glucose level and blood pressure are independent predictors of renal arteriolar hyalinosis. 10 Transplant recipients with diabetes were excluded from our study, and no significant differences in the incidence of hypertension treatment at the time of the late-phase biopsy were observed between the two groups. Although the cyclosporine or tacrolimus trough at the time of the late-phase biopsy were not different between the two groups in our study, a previous study showed that the cyclosporine trough at the time of biopsy 10 years after transplantation was similar between recipients with histological evidence of CNI arteriolopathy and those without. 4 We speculate that the pathogenesis of IHA may be related to long-term exposure to CNI as well as graft aging.
In the present study, older kidney grafts exhibited more IHA lesions, specifically more main IHA lesions. A previous report suggested that CNI nephrotoxicity is caused by vasoconstriction and structural changes in afferent arterioles. 11 Presumably, as the afferent arteriolar injury becomes severe, haemodynamic pressure is applied to the proximal side. A previous study showed that cyclosporine caused a sustained reduction in glomerular blood flow due to vasoconstriction of the proximal segment of the interlobular artery in rats. 12 Another report described the molecular mechanisms of tacrolimus-induced arteriolar hyalinosis in mouse models as an increase in transforming growth factor-β receptor activation, which results in collagen and fibronectin production and subsequent smooth muscle cell injury. 13 We speculate that vasoconstriction of the interlobular artery caused by CNI or direct CNI-induced myocyte injury of the interlobular artery might also contribute to IHA. In this study, the serum creatinine level 2 years after biopsy was significantly higher in the IHA group compared with the non-IHA group in the late-phase biopsies performed ≥8 years after transplantation, despite the absence of a significant difference in the serum creatinine level between the two groups at the time of biopsy performed ≥8 years after transplantation. One study showed that cyclosporine was independently associated with poor allograft function at 10 years after transplantation and was associated with allograft loss. 4 Conversely, other studies indicate that a single cause of allograft failure is logically unsound 14 and that both immune and nonimmune mechanisms of graft injury occur. 15 Indeed, the prevalence of acute antibody-mediated rejection was significantly higher in the IHA group in the present study. However, little evidence is available regarding how severe arteriolopathy with IHA in the late phase after kidney transplantation affects long-term allograft function and how we should establish the most appropriate treatment strategy for these lesions.
The main limitation of this study is that it was not a prospective study. A recent Cochrane database systematic review showed that withdrawal of CNI treatment increased the rate of acute rejection, but long-term data are lacking. 16 Therefore, prospective studies are needed to establish a treatment strategy for severe arteriolopathy, as for IHA in late-phase renal allograft biopsies.
In conclusion, we found that older grafts exhibited more IHA lesions. Furthermore, IHA in renal allografts was associated with severe arteriolopathy. The aah scores were significantly higher in the IHA group compared with the non-IHA group ≥8 years after transplantation as determined by the mean score test.
